Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents - Curumim Project

NCT05225285 is registered in ClinicalTrials.gov with Federal University of Espirito Santo as lead sponsor.

NCT NCT05225285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05225285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents - Curumim Project
Lead sponsor
Federal University of Espirito Santo
Phase
Phase 3
Overall status
Unknown status
Start date
January 21, 2022
Completion date
March 21, 2023
Enrollment
1,120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19